Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors: A Longitudinal Study

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

This study assesses how personal relationships (such as friendships, family relationships, or romantic partners) influence the physical activity (exercise) and well-being of young adult cancer survivors. Researchers also hope to learn how social relationships change after a cancer diagnosis, and how these changes might impact important health behaviors. The information provided may help researchers learn more about better ways to support young cancer patients in the future through interventions that help maintain good social relationships and health levels of physical activity.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 39
Healthy Volunteers: f
View:

• Diagnosed and/or treated with cancer between ages 18-39 at USC hospitals.

• Cancer types prototypical for adolescents and young adults (AYAs) and cancer stages I-III; select patients with stage IV disease may be eligible, with approval by the principal investigator (PI) and in consultation with the treating clinician.

• Must be within three months of a de novo cancer diagnosis at recruitment and on/indicated for curative therapy (any modality). Patients may continue on adjuvant therapy throughout duration of the study.

• Patients must have anticipated survival of \>1-year at time of diagnosis.

Locations
United States
California
USC / Norris Comprehensive Cancer Center
RECRUITING
Los Angeles
Contact Information
Primary
Kimberly A Miller, PhD
kim.miller@med.usc.edu
323-865-0674
Time Frame
Start Date: 2021-11-24
Estimated Completion Date: 2027-12-31
Participants
Target number of participants: 250
Treatments
Observational (actigraph, surveys)
Patients complete surveys and wear an actigraph GT3X-BT accelerometer continuously for 7 days at baseline, 3, 6, and 12 months.
Sponsors
Leads: University of Southern California
Collaborators: National Cancer Institute (NCI)

This content was sourced from clinicaltrials.gov